Safety of OnabotulinumtoxinA with Concomitant Antithrombotic Therapy in Patients with Muscle Spasticity: A Retrospective Pooled Analysis of Randomized Double-Blind Studies

BACKGROUND: OnabotulinumtoxinA is approved as a treatment across multiple indications. For the treatment of spasticity, onabotulinumtoxinA is injected directly into affected muscles. Intramuscular injections may result in local bleeding and related complications, especially in patients receiving ant...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:CNS Drugs
Hlavní autoři: Dimitrova, Rozalina, James, Lynn, Liu, Chengcheng, Orejudos, Amelia, Yushmanova, Irina, Brin, Mitchell F.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2020
Témata:
Original Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7125063/
https://ncbi.nlm.nih.gov/pubmed/32170665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-020-00709-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky